EICHOR
● Recruiting
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition: Acute Myeloid Leukemia · Myelodysplastic Syndrome · Sponsor: Bristol-Myers Squibb
About this study
The purpose of this study is to assess the safety, tolerability, drug levels, drug efficacy and determine the recommended dose of BMS-986497 as a monotherapy, in double combination with Azacitidine and in triple combination with Azacitidine and Venetoclax in participants with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
This description comes directly from the study's public registry record.
Talk to the study team
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
Locations (16)
| Yale-New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| Northwestern Memorial Hospital | Chicago, Illinois, United States | Recruiting |
| Local Institution - 0007 | Boston, Massachusetts, United States | Withdrawn |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Washington University School of Medicine, Siteman Cancer Center | St Louis, Missouri, United States | Recruiting |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Columbia University Irving Medical Center | New York, New York, United States | Withdrawn |
| University of Texas MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Local Institution - 0009 | Fairfax, Virginia, United States | Withdrawn |
| Princess Margaret Cancer Centre | Toronto, Ontario, Canada | Recruiting |
| Jewish General Hospital | Montreal, Quebec, Canada | Recruiting |
| Local Institution - 0017 | Marseille, Bouches-du-Rhône, France | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06419634